Literature DB >> 11706405

GRB2: a pivotal protein in signal transduction.

A M Tari1, G Lopez-Berestein.   

Abstract

The growth factor receptor-bound protein-2 (GRB2) is essential for multiple cellular functions. Inhibition of GRB2 function impairs developmental processes in various organisms and blocks transformation and proliferation of various cell types. GRB2 is most well known for its ability to link the epidermal growth factor receptor tyrosine kinase to the activation of RAS and its downstream kinases, ERK1,2. We recently reported that GRB2 does not link the HER2 tyrosine kinase to the activation of ERK1,2 but to another kinase, AKT. So, different tyrosine kinases may converge on GRB2 for signaling; however, they may not always use GRB2 to effect the same downstream kinases for cellular functions. It is likely that GRB2 will be found to regulate many more kinases because it plays such a pivotal role in signal transduction. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706405     DOI: 10.1016/s0093-7754(01)90291-x

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  29 in total

Review 1.  Examining multiprotein signaling complexes from all angles.

Authors:  Jon C D Houtman; Mira Barda-Saad; Lawrence E Samelson
Journal:  FEBS J       Date:  2005-11       Impact factor: 5.542

Review 2.  You can't go home again: transcriptionally driven alteration of cell signaling by NGF.

Authors:  Lloyd A Greene; James M Angelastro
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

3.  In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.

Authors:  Jason G Weinger; Pouyan Gohari; Ying Yan; Jonathan M Backer; Brian Varnum; Bridget Shafit-Zagardo
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

4.  Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.

Authors:  Xiaoyu Jiang; Xiaoqing Lu; Yu Zhang; Leda Lacaria; Brett J Schuchardt; David C Mikles; Marco Magistri; Idoia García-Ramírez; Isidro Sanchez-Garcia; Amjad Farooq; Ramiro E Verdun; Midhat H Abdulreda; Vincent T Moy; Izidore S Lossos
Journal:  Blood Adv       Date:  2019-08-13

5.  HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.

Authors:  Slava Rom; Marco Pacifici; Giovanni Passiatore; Susanna Aprea; Agnieszka Waligorska; Luis Del Valle; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2011-07-01

6.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

7.  Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist.

Authors:  Alessio Giubellino; Zhen-Dan Shi; Lisa M Miller Jenkins; Karen M Worthy; Lakshman K Bindu; Gagani Athauda; Benedetta Peruzzi; Robert J Fisher; Ettore Appella; Terrence R Burke; Donald P Bottaro
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

8.  Development of a novel bioinformatics tool for in silico validation of protein interactions.

Authors:  Nicola Barbarini; Luca Simonelli; Alberto Azzalin; Sergio Comincini; Riccardo Bellazzi
Journal:  J Biomed Biotechnol       Date:  2010-06-07

Review 9.  Grb2 signaling in cell motility and cancer.

Authors:  Alessio Giubellino; Terrence R Burke; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

10.  Platelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1.

Authors:  Tram Anh Tran; Lisa Kinch; Samuel Peña-Llopis; Lutz Kockel; Nick Grishin; Huaqi Jiang; James Brugarolas
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.